-
Health Commission: 75 newly diagnosed cases of 18 cases imported from abroad on the 12th
Time of Update: 2021-12-01
As of 24:00 on November 12, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1309 confirmed cases (including 21 severe cases), 92229 cured and discharged cases, and 4636 deaths.
-
A variety of new crown oral drugs have progressed to fight the epidemic and still need "combined punches"
Time of Update: 2021-12-01
Feature: A variety of new crown oral drugs have made progress Feature: A variety of new crown oral drugs have progressed and anti-epidemic still needs "combined boxing" Special pape
-
5 new cases in Japan on November 22: 4 in Liaoning and 1 in Yunnan
Time of Update: 2021-12-01
As of 24:00 on November 22, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1,006 confirmed cases (including 8 severe cases), a total of 92,882 cured and discharged cases, and a total of 4,636 deaths.
-
Health Commission: Newly confirmed 62 cases of imported 19 cases overseas on the 8th
Time of Update: 2021-12-01
As of 24:00 on November 8, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1,222 confirmed cases (including 27 severe cases), a total of 92,027 cured and discharged cases, and a total of 4,636 deaths.
-
Japan's VHH antibody new crown treatment plan makes progress in animal experiments
Time of Update: 2021-12-01
Japan's VHH antibody new crown treatment program makes progress in animal experiments Japan's VHH antibody new crown treatment plan has made animal experiment progress Japan's VHH a
-
A variety of key drugs for new coronary pneumonia in my country enter clinical trials
Time of Update: 2021-12-01
A variety of key drugs for new coronary pneumonia in my country enter clinical trials A variety of key drugs for new coronary pneumonia in my country has entered clinical trials Beijing, November 17, reporter Yang Shu learned from the Ministry of Science and Technology recently that China has followed the three technical routes of inhibiting virus replication, blocking virus entry into cells, and regulating the human immune system.
-
The Comprehensive Department of the State Food and Drug Administration publicly solicits opinions on the "Measures for the Supervision and Administration of Drug Operation and Use Quality (Draft for Solicitation of Comments)"
Time of Update: 2021-12-01
The "Measures for the Supervision and Administration of Drug Operation and Use Quality" have been revised and perfected and are now again open to the public for comments .
cn via e-mail before November 26, 2021, and the subject of the email should indicate "Feedback on Drug Operation and Use Measures" .
-
How to prevent about one million patients with sudden acute myocardial infarction every year in my country
Time of Update: 2021-12-01
Chest pain and sweating are the most typical symptoms of patients with acute myocardial infarction .
-
Health Commission: Newly diagnosed 32 local cases on the 14th
Time of Update: 2021-12-01
As of 24:00 on November 14, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1347 confirmed cases (including 17 severe cases), a total of 92,332 cured and discharged cases, and a total of 4,636 deaths.
-
The pharmacy industry has set off a wave of listings, and corporate competition will intensify
Time of Update: 2021-12-01
In August, SpeciHealth, which mainly sells specialty drugs for oncology and other critical diseases, formally submitted a prospectus to the Hong Kong Stock Exchange and plans to list on the main board .
-
NIFDC: "Manual of Reference Materials for Pharmaceutical Excipients and Packaging Materials" compiled and issued by the Excipients and Packaging Materials Institute
Time of Update: 2021-12-01
It provides a list of reference materials for pharmaceutical excipients and pharmaceutical packaging materials of the China National Inspection and Quarantine Institute.
pdf Attachment download: Manual of Reference Materials for Pharmaceutical Excipients and Packaging Materials.
-
Chinese experts take the lead in realizing accurate ultra-low anus preservation for patients with rectal cancer
Time of Update: 2021-12-01
The reporter learned on the 13th that the team of Professor Liu Zhongchen from Shanghai Tenth People's Hospital has successfully developed a new technique for anus-preserving surgery for ultra-low rectal cancer after 10 years .
-
up to date!
Time of Update: 2021-12-01
The Xie Xiaoliang team of Peking University's Biomedical Frontier Center has made important progress in the research of neutralizing antibodies by using single-cell sequencing technology, and the drugs developed have been used in clinical treatment .
-
The Drug Evaluation Center of the State Food and Drug Administration released the "Annual Report on the Current Status of Clinical Trials for New Drug Registration in China (2020)"
Time of Update: 2021-12-01
The follow-up drug review center will report on new drug registration clinical trials on an annual basis, relying on China's new drug registration clinical trial registration data, focus on regulatory innovation, improve regulatory effectiveness, strengthen communication with the industry in promoting the modernization of drug regulatory capabilities, and increase information transparency.
-
Notice on the solicitation of research institutes for general inspection methods for seal integrity of national pharmaceutical packaging materials standards
Time of Update: 2021-12-01
Units intending to undertake research tasks need to fill in the "National Pharmaceutical Packaging Material Standard-General Testing Method for Seal Integrity Research Unit Application Form" (see Annex 2) .
National Pharmaceutical Packaging Material Standard-Application Form of Research Unit for General Testing Methods for Seal Integrity.
-
Basic introduction to American DMF
Time of Update: 2021-12-01
Classification of DMF Type I: production location and plant facilities, personnel Type Ⅱ: Intermediates, APIs and drugs Type Ⅲ: Packaging materials Type IV: auxiliary materials, coloring agents, spices, flavors and other additives Type V: Non-clinical data and clinical data The main content of DMF The DMF file declared by the pharmaceutical excipient manufacturer to the FDA belongs to Type IV .
-
Tsinghua University held the first World Health Forum
Time of Update: 2021-12-01
It is hoped that representatives from all walks of life participating in the forum will uphold the concept of a community of human health and health, strengthen exchanges and build consensus, and make greater contributions to deepening international epidemic prevention and control and health cooperation, and jointly safeguarding the health of mankind in a better future .
-
Health Commission: The overall epidemic situation has stabilized, insisting on "dynamic reset"
Time of Update: 2021-12-01
The epidemic situation in these four places still needs attention Wu Liangyou, deputy director of the National Health Commission's Disease Control Bureau, said at the press conference that at present, the overall epidemic situation across the country has stabilized .
-
Latest International Research: Fatty Acids in Palm Oil Promote Tumor Metastasis in Mice
Time of Update: 2021-12-01
The paper introduced that fatty acid intake and metabolic changes have always been thought to be related to cancer metastasis, which refers to the process by which cancer cells spread to other parts of the body .
-
my country's first injection of new crown specific medicine has significant effect
Time of Update: 2021-12-01
The reporter learned from Beijing Ditan Hospital today that after 35 patients in Beijing used "sympathetic medication" that received China's self-developed neutralizing antibody drug DXP-604, their condition improved significantly in a short period of time .
